A newly published Perspective article in Nature Nanotechnology details groundbreaking nanoparticle technology to eliminate ...

Researchers have developed smart nanoparticles that can seek out and destroy disease-causing proteins the body can’t normally eliminate. Unlike traditional drugs, these particles can reach ...

Learn which nanocarriers matter now (LNPs, exosomes, polymers) and the key hurdles in biodistribution, safety, CMC, and ...

Researchers developed nanotechnology that selectively binds and degrades abnormal proteins. The technology shows promise for ...

A newly released perspective article in Nature Nanotechnology describes an innovative nanoparticle-based approach designed to remove harmful proteins ...

OBJ and Invest Ottawa have partnered to create this recurring feature that will feature up-and-coming tech startups in the ...

CHICAGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, antigen-specific immune tolerance therapies for autoimmune diseases, announced ...

FDA assigns Prescription Drug User Fee Act (PDUFA) target date of June 29, 2026Ended 2025 with unaudited cash position of $41 ...

Dr. Stacy Lindborg is president and CEO of IMUNON, a clinical-stage company in phase 3 development with a lead DNA-mediated immunotherapy for advanced ovarian cancer. Dr. Lindborg has worked in the ...

Imagion Biosystems, Ltd. (ASX: IBX) announced that the company has lodged an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for its MagSense® targeted ...

Nivalon Medical Technologies Inc. has successfully produced the world's first fully patient-specific, motion-preserving spinal implant built entirely without metal, using AI-driven design and advanced ...

Development of effective medications for central nervous system (CNS) disorders has long been plagued by a high failure rate in clinical trials. One ...